FIP in the Media
April 2013
Canadian pharmacists expand services, quote FIP work
MONTREAL — Quebec patients with minor ailments may soon be able replace a trip to the doctor’s office or clinic with one to the neighbourhood pharmacy.
New legislation will expand the role of Quebec pharmacists to tasks that have traditionally been reserved for doctors.
The province’s introduction of Bill 41 drew on recent amendments to pharmacy laws in other Canadian provinces aimed at easing pressure on family doctors, clinics and emergency rooms.
Pharmacists will not be able to diagnose health conditions, but they will be able to extend a prescription for one year, as well as adjust medications and order and interpret laboratory tests that monitor drug use.
Pharmacists will also be able to provide patients with drugs for the prevention of certain conditions, for example, anti-malaria, morning sickness, traveller’s diarrhea and the morning-after pill.
Proposed changes to Quebec’s pharmacy act reflect a growing perception that pharmacists are more than mere pill dispensers.
Alberta was the first province in 2005 to allow pharmacists to extend prescriptions. Quebec’s adoption of Bill 41 is consistent with the concept of “pharmaceutical care” adopted by the World Health Organization and International Pharmaceutical Federation.
Read the full story here
December 2012
FIP published in World Medical Journal
FIP has recently published an article entitled Regulation of Health Professions: Disparate Worldwide Approaches are a Challenge to Harmonization in the World Medical Journal. Access the full publication here.
FIP authors article for World Health Summit
FIP has recently been published in the journal for the 2012 World Health Summit with an article entitled Higher Education and a Needs Based Pharmacy Workforce. Access the full publication here.
October 2012
FIP mentioned in document on setting health system policies via pharmaceutical care
In a new report by the European Directorate of the Quality of Medicines & Healthcare at the Council of Europe entitled Pharmaceutical care – policies and practices for a safer, more responsible and cost-effective health system FIP is mentioned several times for work in this area.
Click here to access the online document.
August 2012
FIP President contributes to Prescrire
FIP President Michel Buchmann recently contributed to an article in Prescrire, August edition, 32:346, pages 606-609 (not available online) but title can be seen as ‘Pharmaciens d'officine : vision d'avenir’ [A vision of the Future for community pharmacy]
June 2012
FIP President contributes to article on person- and people-centred care
FIP President Michel Buchmann recently contributed to an article entitled The pharmacist’s perspective to advance person- and people-centered care.
Click here to read the full article.
May 2012
FIP Congress Director Carola van der Hoeff featured in Association Event Planner Magazine
Carola van der Hoeff, FIP's resident Congress Director, has recently been featured in Association Event Planner Magazine, highlighting her work since becoming part of the FIP team and the success of the last FIP Congress in Hyderabad, India.
Read the full story here.
FIP Centennial in the German Media
Prof. Dr. Martin Schulz recently promoted the FIP Centennial in the German Pharmazeutische Zeitung. Read the full story here (German).
March 2012
FIP quoted in article on medicines shortages
L'actualité.com, a French Canadian news magazine, has quoted FIP work in an article on medicines shortages. Read the full article here.
FIP noted in APhA Article on Counterfeit Medicines
The FIP website was cited in a recent article released by the American Pharmacists Association (APhA) entitled Role of the Pharmacist in Preventing Distribution of Counterfeit Medications.
Read the full article here.
PSI Launches Forum, Announces FIP Congress 2013
The Taoiseach Enda Kenny TD, with the Pharmaceutical Society of Ireland (PSI), the pharmacy regulator, has today launched new structures of education and training for pharmacists in Ireland which will oversee their continuing professional development (CPD) as well as implement a new best-practice pharmacist education system. The PSI also announced that it had won a major international pharmaceutical congress [FIP] for Ireland to take place in 2013.
Read the full story here
November 2011
FIP Diabetes Report makes headlines
BioPortfolio publishes FIP's report for World Diabetes Day - Pharmacists' contributions to diabetes care
See more here
October 2011
FIP President Michel Buchmann's presentation cited re counterfeit meds
The online French publication IMPACT-SANTE recently reported on FIP President Michel Buchmann's presentation on counterfeit medicines, paying special attention to the role of pharmacists in fighting this global problem.
Read the full story here
August 2011
‘71st FIP will enhance image of Indian pharma sector'
Persistant efforts have made it possible for the Indian host committee to bring an international event like International Pharmaceutical Federation (FIP) to India this year. Ajit Singh, Expert Member, Bureau of Pharmaceutical Sciences, FIP and chairman, ACG Worldwide shares details of his role as a committee member and the potential of the event with Usha Sharma.
Read the full story here
July 2011
FIP in ExpressPharma India
As the FIP Congress moves to India for the first time, Prafull D Sheth,Vice President, FIP gives Express Pharma a behind-the-scenes glimpse of the organisation behind the landmark event
Read the full story here
May 2011
FIP Visits China
The Chinese Pharmaceutical Association (CPA) was pleased to report a visit of FIP President Dr Michel Buchmann and FIP CEO Mr Ton Hoek.
The full report can be found on the CPA website here (translated version).
April 2011
Pharmacy Education Taskforce in the Lancet
The Pharmacy Education Taskforce had a letter published in the Lancet in response to an article about transforming health professional education.
Transforming health professionals' education. By - Pharmacy Education Taskforce Advisory Group
To see the full text click here
Congratulations to our Advisory Group Team!
February 2011
FIP Endorses WEF Global Health Data Charter
The World Economic Forum today launches an ambitious project to advance global health through improved data collection and management. The Global Health Data Charter recognizes that accurate health data is essential for effective and efficient health management. The Charter aims to enable individuals and patients, health professionals and policy-makers to make more informed decisions through secure access to comprehensive, quality data.
Read the full story here
November 2010
WHPA mobilises action against counterfeit medical products
PRIOR to its meeting in Abuja which opened Monday in Abuja, the World Health Professions Alliance, WHPA, has been urging further action against counterfeiting of medical products that puts human lives at risk and undermines the credibility of health systems.
The conference holding at the International Conference Center,is the platform through which the body is expressing its concern about the infiltration and sale of counterfeit medical products in the legitimate supply chainin Nigeria and around the world.
Read the full story here
April 2010
FIP Interview Featured in the Center for Global Development Newsletter
FIP CEO Mr Ton Hoek and Manager for External Partnerships Mr Xuanhao Chan were featured in an interview conducted by the Center for Global Development on drug resistance support for the DRWG's recommendation to strengthen developing country drug prescribing and dispensing practice. Read the full interview here.
February 2010
FIP and Pharmaceutical Sciences 2020 Commended in
Nature Reviews|Drug Discovery
FIP is extremely pleased to announce that the article published by the FIP Board of Pharmaceutical Sciences, under the authorship of Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah,
Kamal Midha and Hubert Leufkens entitled Pharmaceutical Sciences in 2020 has been featured in Nature Reviews|Drug Discovery. Click here to download the full article. Congratulations!
January 21 2010
FIP and the Tripartite action for Global Pharmacy Education
The site allAfrica.com mentioned FIP and its partners in Global Pharmacy Education in the article "Pharmacists Urge Creation of Food, Drugs Unit in Health Ministry", which reported that pharmacists under the [FIP Member Organisation] the Pharmaceutical Society of Nigeria "have called for the creation of Foods and Drugs Services Department (FDSD) at the Ministry of Health, charged with the responsibility of developing pharmaceutical care in teaching and specialist hospitals and Federal Medical Centres across the country". Read the full article here.
January 15 2010
FIP named in the Fight Against Counterfeit Medicines
The Indian Pharmacy Portal PHARMABIZ.com mentioned the FIP-WHO project to evaluate counterfeit medicines in India. Read the full article here.
November 13 2009
MEPS Pictograms story in the Pharmaceutical Journal
An extensive article on the FIP Military and Emergency Pharmacy Section's Pictogram Project has appeared online in the Pharmaceutical Journal - click here for the story!
October 27 2009
Pharmacy Education Taskforce - articles published
The Taskforce has had an article published in the online development magazine Health Exchange News about the country case study workshop held in Nairobi, Kenya, this summer. Check it out here
Tana Wuliji's article on pharmacy workforce migration also appeared in this issue here
October 21 2009
WHO-FIP Developing Pharmacy Practice, Spanish version
Click here for a Spanish article announcing the FIP-WHO Handbook on Development Pharmacy Practice
September 29 2009
FIP Congress in the Media!
WHO reports on Joint Symposium - click here
Special eight page section in the Pharmaceutical Journal - click here
www.lfi.is (Iceland)
JuridoBrasil.com (Brazil)
Segs.com (Brazil)
Anf.pt (Here read more about an Award Winning Poster Presentation at the FIP Congress Istanbul [Portuguese])
Cofares.es (Spain)
September 29 2009
The Straits Times - FIP is referenced on the topic of Self Medication in an article entitled 'DIY Cures'. Read the full article here
As stated online:
DIY cures
By: June Cheong, The Straits Times
All of us 'play doctor' to ourselves, some more so than others.
You are self-medicating when you reach for that Panadol whenever you have a headache, skipping a visit to the doctor in the process.
Self-medication is the use of non-prescription medicines by people on their own initiative, according to the International Pharmaceutical Federation.
'It requires consumers to make their own decisions in selecting and using medication to relieve or treat their medical conditions,' said
Ms Lita Chew, vice-president of the Pharmaceutical Society of Singapore.
'Responsible self-medication entails recognising when self-treatment is appropriate and when a visit to the family doctor for diagnosis and treatment is necessary,' she said.
Besides saving on doctors' fees and prescriptions, people who self-medicate help take the pressure off medical services, which are often over-subscribed.
However, while many minor ailments like fungal skin infections or the common cold can be treated with medicine bought over the counter, medical professionals caution that there are limits to self-medication.
...
Click here for full article
September 20 2009
FIP Pharmabridge Project makes the news -click here
September 2 2009
As stated online at Medilexicon.com:
Global Health Professions Urge Action On H1N1 Pandemic
A call to action to prepare for an H1N1 pandemic at a country and community level has been issued by the World Health Professions Alliance.
The WHPA, a body that brings together more than 23 million health care professionals worldwide, has endorsed a set of key principles to promote operational activities that can be implemented at the country level in response to the continued spread of the H1N1 pandemic. The principles have been developed by the World Health Organization, UNICEF, the International Federation of the Red Cross and Red Crescent and the UN Office for the Coordination of Humanitarian Affairs. They reemphasize some key interventions and directly complement current World Health Organisation technical guidance and National Pandemic Influenza plans.
The Alliance, which unites dentistry, medicine, nursing, and pharmacy through their representative international organisations, the International Council of Nurses, the International Pharmaceutical Federation, the World Dental Federation and the World Medical Association, says these interventions are designed to strengthen and build on existing systems at country level and they call on all partners to integrate them into ongoing programmes.
Read full article here
August 3 2009
FIP President Kamal K. Midha cited for speaking at 74th Annual Conference of the Pharmaceutical Society of Ghana (PSGH), click here to link to the online article
As stated online:
Ghana to start ambitious malaria elimination programme in October
NEW. Watch live television from Ghana plus the latest Ghanaian movies plus OBE TV.
Accra, Aug. 3, GNA - The Ministry of Health (MOH) would embark on a National Malaria Elimination Programme in October, to make Ghana the first country in Africa to eliminate the disease.
Dr George Sipa- Adjah Yankey, the Sector Minister who made this known in Accra said: "I believe that this is the time for us to wage a decisive war on malaria. I have heard a number of scientists say that we cannot eradicate malaria. The difference between me and my team of scientists. is that as a Minister, I am allowed to dream and provide the leadership," he said.
The minister, who made this known at the 74th Annual Conference of the Pharmaceutical Society of Ghana (PSGH), said he was liaising with his counterparts in Nigeria, Togo, Burkina Faso, La Cote d'Ivoire and Mali to make the programme a success.
The conference on the theme: "Managing Threats and Crisis: The Vital Role of Pharmacy in an Unstable World," is a prelude to the 10th Commonwealth Pharmacists Association Conference, which takes place in Accra from August 5- August 9.
Dr Yankey said malaria was a looming crisis since resistance was slowly developing against the best arsenal, which was the artemisinin based products.
The Health Minister noted that it does not make economic sense if Ghana continue to spend more than 760 million dollars annually to combat malaria. "It is morally right if we work to save those children who loose the battle with malaria every minute," he added. Dr Yankey called for the support of pharmacists to communicate the message that would enable the public to understand their role in managing the malaria crisis.
In response to a request by Dr Alex Dodoo, President of PSGH, for government to separate the prescription and dispensation of drugs under the National Health Insurance Scheme (NHIS), the Minister announced a team, with Dr Dodoo as Chairman to streamline the situation. Dr Yankey expressed the need for health providers to view every patient as a potential source of data, saying all drug outlets are a valuable source of information "We need as a matter of urgency to put in place a system that will enable such information to be systematically captured and fed into policy."
Dr Dodoo said there was evidence that when one person provided prescribing and dispensing services within any health insurance scheme, there was the over prescribing of medicines. He contended that for several reasons dispensing doctors cost insurance schemes much more than non -dispensing doctors. "Dispensing doctors are known to prescribe more branded medicines than non-dispensing doctors; to prescribe antibiotics for simple ailments than their counterparts who do not dispense, and also to cost the health insurance scheme much more money," he said. He called on managers of the NHIS to speed up the reimbursement of pharmacies, which supply medicines and other health commodities under the scheme.
Dr Dodoo said the PSGH was also committed to the promotion of a strong and active pharmaceutical industry, geared towards wealth creation, health promotion and employment generation to ensure that Ghana became the leading centre for pharmaceutical sciences and pharmaceutical industry activities in sub-Saharan Africa. Dr Dodoo said the PSGH was counting on the support of the International Pharmaceutical Federation (FIP) to provide extensive skills, dynamic networks and global advocacy to help make the Ghanaian Pharmaceutical industry the best in Africa.
Professor Kamal Midha, President of FIP, who spoke on "Improving Public Health in Ghana; Pharmacists Role and Responsibilities," expressed concern about the flooding of the market with counterfeit drugs, which posed a threat to public health and asked pharmacists to be at the forefront to fight the menace. He stressed the need for the improvement of pharmacy education and forging of closer collaboration between the PSGH and other stakeholders to ensure effective drug administration. The PSGH conferred honorary fellowship award on Prof. Midha for his meritorious duties to the FIP, which attracts more than two million pharmacists.
July 2009
2011 FIP Congress Announced on Pharmabiz, click here to link to the website
As stated online:
India to host prestigious 'FIP Annual Congress' in September, 2011
For the first time in its around 100-year old history, the International Pharmaceutical Federation (FIP), the 132-member global association of national associations of pharmacists and pharmaceutical scientists will be holding its annual congress in India at Hyderabad from September 1 to 8 in 2011.
The event is significant as the Indian pharmacy profession and education will get a big global exposure due to the FIP congress. It will be a good opportunity for the country to showcase its pharmacy profession and education to the world. The Indian Pharmaceutical Association (IPA) is taking the lead in organising this world event for the first time in India.
Over 3000 pharmacists, pharmaceutical scientists, academics, researches, students and press from 120 countries across the world are expected to be in the country to participate in sessions, workshops and discussions focused on pharmacy and education. IPA president Dr B Suresh said that the event will be a good opportunity for the country to showcase the progress made in the field of pharmacy profession and education to the world leaders.
Dr Suresh said that the FIP's priorities have expanded both literally and figuratively to meet the needs and expectations of the profession in expanding healthcare services and integrating emerging scientific developments in the world. Changes in pharmacy and the emergence of pharmacy practice as a cornerstone of the profession have led FIP to become globally visible for its advocacy on behalf of the role of the pharmacist in providing healthcare, while still maintaining its grounding in the pharmaceutical sciences.
Through the work of various individuals, working groups and taskforces, FIP initiates and implements numerous projects and programmes that are making a significant impact within global pharmacy practice, pharmaceutical sciences and community health.
Every year, FIP organises the World Congress of Pharmacy and Pharmaceutical Sciences, where thousands of pharmacists meet, learn, share and exchange views. Lectures, plenary sessions, poster exhibitions and section programmes, together with Council meetings and the Leadership Conference make this event the premier international event in pharmacy each year. The social side - finding new friends and greeting old ones - complements the varied Congress programme. The annual Congress also serves the young pharmacists group with specially planned sessions and workshops focussed on current issues facing this unique segment of the profession.
December 2008
Article on the FIP President Dr Kamal K Midha appeared on the pharmadanmark website on behalf of the FIP Danish Member Organisation, http://www.fip.org/www/index.php?page=mo_im_pharmacy
Download the PDF here!
Taken from Destination Sante, Health News Agency
AIDS must not be allowed to mask another vital battle - that against TB
[9 December 2008 - 08:37]
AIDS must not be allowed to mask another vital battle - that against TB
Medication alone cannot conquer the AIDS pandemic, but it can achieve a great deal. Providing it's used properly!
This obvious fact was at the centre of the debates at the 8th International Conference on AIDS and Sexually Transmissible Infections (STIs) held in Dakar (Senegal). Because although observance of treatment is fundamental to success, the fact that HIV is being treated must not overshadow the need for treatment of opportunistic diseases. And at the forefront of these is tuberculosis.
As Alastair Reid of UNAIDS reminds us, tuberculosis "is the principal cause of illness and mortality among people living with HIV in Africa. And yet it can be treated and avoided...". In Dakar, in association with the Stop TB Partnership and the World Food Programme, the Agency ran sessions on the implementation of what it calls "the three ‘I's rule: Intensification of TB screening; preventive use of Isoniazide (anti-TB reference drug, ed.); and Infection control to reduce the burden of TB". An invaluable and timely reminder is that "in 2006, for example, only 22% of people affected by TB in sub-Saharan Africa were tested for infection with HIV. And less than 1% of HIV-positive patients received screening for TB..."
Once the illness has been unmasked, therapeutic observance is an absolute imperative. In this respect, the role of those in charge of town pharmacies - known in international jargon as community pharmacies- is absolutely essential. The Sidaction association in fact ran a "reinforcement session" aimed specifically at them. This reiterated the importance of the "Good Pharmaceutical Practice Guide drawn up by the International Pharmaceutical Federation (IPF) following lengthy consultation with pharmacists' professional associations across the world. Simple and locally adapted "it helps to improve all practices, from stock management, via nutritional recommendations, to advice when dispensing."
France's commitment will not be challenged by the crisis Because everything matters. "How can we identify and support patients who fail to observe treatment; how can we adapt the taking of antiretrovirals during Ramadan?" These are the questions facing pharmacists on a daily basis and their "role and importance (...) must be better recognised. They must be better integrated into proposed in-service training", Sidaction representatives point out.
Screening, promoting information, patient education, in-service training for professionals in the field ... there is no shortage of imperatives. The fight against HIV in Africa has perhaps made more headway in the last 6 years than during the previous 20 but while progress has been immense, the challenge remains considerable. And Africa will not face it alone. International support is more necessary than ever because HIV knows no boundaries. Any more than any other disease.
"Be assured that France will not abandon its substantial contribution to the World Fund - the leading contribution in terms of size in the European Union and the second largest in the world - nor its very considerable participation in UNITAID". Roselyne Bachelot-Narquin, French minister responsible for health, is leading the way in this respect. And she reminds us that in 2007 "France committed more than 364 million euros to this fight (and that there) can never be a question of abandoning these diplomatic priorities as a result of the global economic and financial crisis."
Published article in the European Journal of Hospital Pharmacy Practice, Autumn 2008
Safe internet buying of medicines - how and why pharmacists should help
Published articles in the European Journal of Hospital Pharmacy Practice, Summer 2008
The role of hospital pharmacists in counterfeit medicines
Counterfeit Medicines - it will never happen to me
Articles listed above from the European Journal of Hospital Pharmacy Practice reprinted with permission from Pharma Publishing and Media Europe
15 August 2008
Taken from Medical News Today, http://www.medicalnewstoday.com/articles/118278.php
Leading Scientists To Present At Bio-International 2008 Conference, UK
Leading scientists in the fields of biopharmaceutics, bioequivalence and clinical pharmacology will meet in London from 22 to 24 October for the annual Bio-International Conference.
The event, named Bio-International 2008: Towards Improved Harmonization in Regulating Multisource Products, aims to develop a common approach for tackling complex bioequivalence issues such as interchangeability of cytotoxic, topical and respiratory drug products.
Some of the burning issues this year include the use of comparator drug products for establishing bioequivalence, and the application of the Biopharmaceutics Classification System in assessing bioequivalence of oral products. There will also be a special session highlighting bioequivalence issues in many countries and how these can be resolved with the experience gained in other parts of the world.
The conference will be preceded by a satellite workshop on 20 to 21 October, titled Special Dosage Forms - What's new with in vitro drug release?, which will focus on drug release testing and methodologies to evaluate product performance for special dosage forms. Both events are organised by the Royal Pharmaceutical Society of Great Britain (RPSGB) and the International Pharmaceutical Federation (FIP), and will be held at the RPSGB's headquarters in London. Delegates are invited to sign up for both events for a discounted combined fee.
Jayne Lawrence, the RPSGB's Chief Scientific Advisor, said: "Bio-International 2008 provides an excellent forum for discussion and development of consensus amongst pharmaceutical scientists working in the areas of biopharmaceutics, bioequivalence and clinical pharmacology.
The two events also offer good opportunities for professionals in these areas to interact and network with each other. I encourage anyone with an interest in these subjects to attend." For further details about these events, please see http://www.rpsgb.org/events or email science@rpsgb.org.
Notes:
Bio-International 2008 is presented by the Royal Pharmaceutical Society of Great Britain (RPSGB) and the International Pharmaceutical Federation (FIP) in cooperation with the American Association of Pharmaceutical Scientists (AAPS) and the European Federation for Pharmaceutical Sciences (EUFEPS).
The satellite workshop is presented by the RPSGB and the FIP Dissolution / Drug Release Special Interest Group (SIG).
18 January 2008
FDA & IFPMA Officials to Chair Anti-Counterfeiting Conference
on Interaction of Regulatory & Technological Approaches
1st Public Forum for WHO-led IMPACT Coalition: Singapore, 13-15 Feb 2008
Geneva, 17 January 2008 - The WHO-led International Medical Products Anti-Counterfeiting Taskforce (IMPACT) will hold its first public meeting in Singapore, 13-15 February 2008. The IMPACT Forum will address the theme “Combating Counterfeit Medicines: Where the Regulatory and Technology Roads Meet” and will be co-chaired by Dr. Ilisa Bernstein, Director of Pharmacy Affairs at the US Food and Drug Administration and Dr. Harvey Bale, Director General of the IFPMA.
Speaking in her capacity as Chair of the IMPACT Working Group on Regulatory Implementation, Dr. Bernstein commented: “Anti-counterfeiting technologies are evolving fast and the field is an increasingly complex one. Pharmaceutical manufacturers and regulators have an interest to keep themselves informed about developments and this IMPACT Forum should provide a handy means of doing so.”
Dr. Bale, who is also Chair of the IMPACT Technology Working Group, remarked: “Patients everywhere should benefit from new technologies designed to help protect the integrity of the pharmaceutical supply chain. Counterfeiting is a growing problem in many developing countries and their regulatory authorities should consider using appropriate technologies to verify the authenticity of medicines.”
The IMPACT Forum will feature two distinct sections. It will start with presentations on different technological solutions by provider companies and will continue with a discussion on how to make it easier for developing countries to use technology to good effect to combat counterfeit medicines. The Forum will be opened by Dr. John Lim, CEO of Singaporean Government’s regulatory body, the Health Sciences Authority (HSA), and is being co-organized by WHO, the IFPMA and the International Pharmaceutical Federation (FIP), which represents pharmacists associations worldwide.
To register for the Forum, please complete and submit the attached Registration Form. For more information about the Forum program, plus exhibition and sponsorship opportunities, please go to http://www.impactglobalforum.org/.
About the IFPMA:
The International Federation of Pharmaceutical Manufacturers & Associations is the global non-profit NGO representing the research-based pharmaceutical, biotech and vaccine sectors. Its members comprise 25 leading international companies and 46 national and regional industry associations covering developed and developing countries. The industry’s R&D pipeline contains hundreds of new medicines and vaccines being developed to address global disease threats, including cancer, heart disease, HIV/AIDS and malaria. The IFPMA Clinical Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s Ethical Promotion online resource (www.ifpma.org/EthicalPromotion/) and its Health Partnerships information (www.ifpma.org – Developing World) help make the industry’s activities more transparent. The IFPMA strengthens patient safety by improving risk assessment of medicines and combating their counterfeiting. It also provides the secretariat for the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).
For further information, please contact:
Guy Willis
Director of Communications, IFPMA
E-mail: g.willis@ifpma.org
Tel: +41-22-338 32 00
Fax: +41-22-338 32 99
Web: www.ifpma.org
| 11 January 2008 |
FDA & IFPMA Officials to Chair Anti-Counterfeiting ConferenceOn Interaction of Regulatory & Technological Approaches
1st Public Forum for WHO-led IMPACT Coalition: Singapore, 13-15 Feb 2008 |
| 24 April 2007 |
Dutch Minister of Education, Culture and Science Opens the Pharmaceutical Sciences World Congress, AmsterdamPlasterk - “The world absolutely needs more drugs” |
| 19 April 2007 |
WORLD’S LEADING PHARMACEUTICAL SCIENTISTS MEET FOR THE FIRST TIME IN EUROPEOver 2500 scientists, researchers and academics will soon be welcomed by the Board of
Pharmaceutical Practice of the International Pharmaceutical Federation (FIP), the hosts of the
Pharmaceutical Sciences World Congress 2007 in Amsterdam. All will convene to take in lectures,
workshops, satellite symposia and poster presentations, all in total numbering over 1000, making the
PSWC the biggest and most significant global event in the field. |
